Douglas J. Hughes, Director at Immunovant, Inc. (IMVT), sold 28,091 shares at $23.14 ($652K) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($652k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.14 | 13,091 | $303K | 46.5% |
| 2 | $23.14 | 13,091 | $303K | 46.5% |
| 3 | $23.96 | 1,909 | $46K | 7.0% |
| Total | $23.20 avg | 28,091 | $652K | 100% |
| Filing → |
| EAR | SELL | 2021-04-28 | $83K | — | Filing → |